APA (7th ed.) Citation

Adeberg, S., Akbaba, S., Uzun-Lang, K., Held, T., Verma, V., Nikoghosyan, A., . . . Jensen, A. (2020). The phase 1/2 ACCEPT trial: Concurrent cetuximab and intensity modulated radiation therapy with carbon ion boost for adenoid cystic carcinoma of the head and neck. International journal of radiation oncology, biology, physics, 106(1), . https://doi.org/10.1016/j.ijrobp.2019.09.036

Chicago Style (17th ed.) Citation

Adeberg, Sebastian, et al. "The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck." International Journal of Radiation Oncology, Biology, Physics 106, no. 1 (2020). https://doi.org/10.1016/j.ijrobp.2019.09.036.

MLA (9th ed.) Citation

Adeberg, Sebastian, et al. "The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck." International Journal of Radiation Oncology, Biology, Physics, vol. 106, no. 1, 2020, https://doi.org/10.1016/j.ijrobp.2019.09.036.